AQST Financials
Aquestive Therapeutics Inc - Financial statements & key metrics
Stock Price
$4.27
Market Cap
$512.41M
EPS
$-0.70
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$57.56M
Gross Profit
-
Operating Income
-
Net Income
$-44.14M
EPS (Diluted)
$-0.51
Balance Sheet Highlights
Total Assets
$101.42M
Total Liabilities
$161.58M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-35.76M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
58.3%
Operating Margin
-2.2%
Net Margin
-1.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AQST revenue?
AQST's most recent quarterly revenue was $57.56M. Annual revenue can be calculated by summing the four most recent quarters.
Is AQST profitable?
AQST reported a loss of $44.14M in the most recent quarter. The net profit margin is -1.9%.
What is AQST market cap?
AQST has a market capitalization of $512.41M, making it a small-cap stock.
Does AQST have debt?
View AQST's balance sheet for debt information.
What is AQST cash flow?
Cash flow data is available in the full financial statements.